Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
After finishing at $1.3 in the prior trading day, PDS Biotechnology Corporation (NASDAQ: PDSB) closed at $1.22, down -6.15%. In other words, the price has decreased by -$6.15 from its previous closing price. On the day, 0.58 million shares were traded. PDSB stock price reached its highest trading level at $1.2995 during the session, while it also had its lowest trading level at $1.16.
Ratios:
Our goal is to gain a better understanding of PDSB by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.92 and its Current Ratio is at 2.92. In the meantime, Its Debt-to-Equity ratio is 1.16 whereas as Long-Term Debt/Eq ratio is at 0.81.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, B. Riley Securities on November 01, 2022, initiated with a Buy rating and assigned the stock a target price of $10.
H.C. Wainwright Upgraded its Neutral to Buy on November 10, 2020, while the target price for the stock was maintained at $6.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 28 ’25 when Freitag Gregory Gene bought 15,060 shares for $1.66 per share. The transaction valued at 25,000 led to the insider holds 61,213 shares of the business.
Glover Stephen C. bought 15,061 shares of PDSB for $25,001 on Feb 28 ’25. The Director now owns 78,851 shares after completing the transaction at $1.66 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PDSB now has a Market Capitalization of 60156980 and an Enterprise Value of 43555972.
Stock Price History:
The Beta on a monthly basis for PDSB is 1.14, which has changed by -0.58361775 over the last 52 weeks, in comparison to a change of 0.20221436 over the same period for the S&P500. Over the past 52 weeks, PDSB has reached a high of $4.29, while it has fallen to a 52-week low of $0.85. The 50-Day Moving Average of the stock is 0.26%, while the 200-Day Moving Average is calculated to be -15.29%.
Shares Statistics:
The stock has traded on average 514.80K shares per day over the past 3-months and 779730 shares per day over the last 10 days, according to various share statistics. A total of 46.63M shares are outstanding, with a floating share count of 44.87M. Insiders hold about 3.78% of the company’s shares, while institutions hold 15.88% stake in the company. Shares short for PDSB as of 1755216000 were 1915584 with a Short Ratio of 3.72, compared to 1752537600 on 2444643. Therefore, it implies a Short% of Shares Outstanding of 1915584 and a Short% of Float of 4.24.
Earnings Estimates
Current recommendations for the stock of the company come from 3.0 analysts. The consensus estimate for the next quarter is -$0.21, with high estimates of -$0.15 and low estimates of -$0.29.
Analysts are recommending an EPS of between -$0.74 and -$0.96 for the fiscal current year, implying an average EPS of -$0.82. EPS for the following year is -$0.73, with 3.0 analysts recommending between -$0.58 and -$0.9.
